GlaxoSmithKline's booming Shingrix, after VIP invite, wins nod to tackle China

GlaxoSmithKline's booming Shingrix, after VIP invite, wins nod to tackle China

Source: 
Fierce Pharma
snippet: 

GlaxoSmithKline’s shingles vaccine Shingrix has continuously impressed industry watchers with its explosive growth. Now, the company has added another large market to its list: China.